Dosimetry of large electron beam fields and treatment protocol for mycosis fungoides using the total skin irradiation technique by Pagnan-González, M.A. et al.
Medicina e Investigación 2015;3(1):22--29
www.elsevier.es/rmi
Medicina e
Investigación
ORIGINAL ARTICLE
Dosimetry of large electron beam ﬁelds and treatment
protocol for mycosis fungoides using the total skin
irradiation technique
M.A. Pagnan-Gonzáleza, J.O. Hernández-Oviedob, E. Mitsouraa,∗
a Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, Estado de México, México
b Unidad de Radioterapia, Centro de Cáncer, The American British Cowdray Medical Center, Mexico City, Federal District, Mexico
Received 13 October 2014; accepted 21 October 2014
Available online 26 March 2015
KEYWORDS
Total skin irradiation;
Electrons;
Mycosis fungoides
Abstract
Introduction: Total Skin Electron Beam Therapy (TSEBT) is a technique used in the treatment
of superﬁcial skin diseases, such as cutaneous lymphomas. Although it has demonstrated its
effectiveness through several clinical studies of the advanced stages of mycosis fungoides, it
is not available in most cancer centers in Mexico, because it requires large electron ﬁelds in
order to cover the entire body.
Objective: In order to obtain large electron ﬁelds for TSEBT, conventional treatment distances
are not sufﬁcient. This has led to the need for an electron beam with special features and
calibration at a distance of 500 cm or more, as well as the need to create a treatment protocol
to develop the TSEBT programs in Mexico.
Materials and methods: The ELEKTA SYNERGY Linear Accelerator was selected with a 6 MeV
energy at a Source Skin Distance (SSD) of 500 cm, in high dose rate mode (1,000 MU=100Gy),
using a cone of 40×40 cm2 and the gantry angled to 90◦, obtaining a large electron ﬁeld of
200×100 cm2 useful area. Routine calibration was performed at a Zref=1.40 cm and an SSD of
100 cm with a 40×40 cm2 cone using a plane-parallel ionization chamber and electrometer
(Scandotronix Wellhofer model PPC05 FOCUS) and a water phantom. The same procedure for
the absolute dose rate determination was also performed in treatment conditions (500 cm).
For the beam characterization in terms of Percentage Depth Dose (PDD) and beam proﬁles,
Radiochromic Gafchromic® EBT2 ﬁlm (RCF) was used, after being calibrated for electrons in
a solid water phantom (Scanditronix Wellhöfer) at a 1.4 cm depth and Source Axis Distance
(SAD) of 100 cm and 500 cm, in order to acquire the equation relating the dose response with
optical density. PDD was obtained at 0, 1, 1.2, 1.4, 1.5, 2, 3, 4, 5, 6, 7, 8 and 9 cm depths in
the phantom. Spatial dose distribution was obtained by placing 3×3 cm2 samples of RCF on an
acrylic screen situated in front of the patient (for the purpose of obtaining maximum absorbed
dose on the skin). Lastly, a treatment protocol was proposed.
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Results: An effective maximum dose depth (Zref) for electrons of 1.4±0.05 cm was obtained
according to the relative spatial dose distribution and the percentage depth dose for a SSD of
500±0.5 cm, over an area of 200×100 cm2. Horizontal and vertical beam proﬁles were plotted,
showing a horizontal symmetry of ±0.35%, horizontal ﬂatness of ±3.62%, vertical symmetry of
±2.1%, and vertical ﬂatness of ±14.2%.
Conclusions: The resulting horizontal and vertical proﬁles enabled the electron beam symmetry
and ﬂatness to be assessed. PDD was analyzed up to a 9±0.05 cm, establishing the electron depth
penetration to ensure treatment of the skin surface.
© 2014 Universidad Autónoma del Estado de México. Published by Masson Doyma México S.A.
All rights reserved.
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Dosimetría de los grandes campos de electrones y protocolo de tratamiento de la
micosis fúngica utilizando la técnica de irradiación cutánea total
Resumen
Introducción: La terapia total de piel con haz de electrones (TSEBT) es una técnica usada en
el tratamiento de enfermedades superﬁciales de piel tales como linfomas cutáneos. Aunque su
efectividad ha sido demostrada a través de varios estudios clínicos en estadios avanzados de la
micosis fungoide, no es una técnica disponible en muchos centros de cáncer en México debido
a que se requieren campos grandes de electrones para cubrir un cuerpo entero.
Objetivo: Para obtener campos grandes de electrones para TSEBT, las distancias convencionales
de tratamiento no son suﬁcientes. Esto trae la necesidad de una caracterización y calibración
especial del haz de electrones a distancias de 500 cm o más y la necesidad de crear un protocolo
de tratamiento para TSEBT en nuestro país.
Materiales y métodos: Para la puesta en marcha de esta técnica fue seleccionado el acelerador
lineal ELEKTA SYNERGY, con una energía de 6 MeV a una distancia fuente-superﬁcie (SSD) de
500 cm, en modo de alta tasa de dosis (1,000 UM = 100Gy), usando un cono aplicador de 40
× 40 cm2 y el ángulo de gantry de 90◦, obteniendo un campo grande de electrones de 200
× 100 cm2 (área útil). La calibración de rutina fue realizada a una profundidad de referencia
(Zref) de 1.4 cm a una SSD de 100 cm y un cono aplicador de 40 × 40 cm2 usando una cámara de
ionización de placas plano-paralelas y un electrómetro (Scandotronix Wellhofer modelo PPC05
FOCUS) y un maniquí de agua. El mismo procedimiento fue realizado para determinar la tasa
de dosis absoluta en condiciones de tratamiento (500 cm). Para la caracterización del haz de
electrones en términos de porcentaje de dosis a profundidad (PDD) y perﬁles de dosis, se
utilizó Película Radiocrómica Gafchromic EBT2 (PRC), después de ser calibrada para electrones
en un maniquí de agua sólida (Scandotronix Wellhofer) a un Zref = 1.4 cm de profundidad a
una Distancia Fuente Isocentro SAD de 100 cm y de 500 cm, para obtener la ecuación de la
dosis en respuesta de la densidad óptica. La PDD fue obtenida a 0, 1, 1.2, 1.4, 1.5, 2, 3, 4,
5, 6, 7, 8 y 9 cm de profundidad en el maniquí. La distribución espacial de dosis fue obtenida
colocando muestras de PRC de 3 × 3 cm2 sobre la pantalla de acrílico que será situada enfrente
del paciente (para así obtener la dosis absorbida máxima en piel). Por último, fue propuesto
un protocolo de tratamiento.
Resultados: La profundidad de dosis máxima (Zref) para electrones fue de 1.4 ± 0.05 cm, de
acuerdo con la distribución de dosis espacial relativa y el porcentaje de dosis en profundidad
para una SSD de 500 ± 0.5 cm, sobre un área de 200 × 100 cm2. Se graﬁcaron los perﬁles del
haz tanto horizontal como vertical, mostrando una simetría horizontal de ±0.35%, aplanado
horizontal de ±3.62%, simetría vertical de ±2.1% y aplanado vertical de ±14.2%.
Conclusiones: Los resultados de los perﬁles horizontal y vertical permiten evaluar la simetría
y aplanado del haz de electrones. El PDD fue analizado hasta 9 ± 0.05 cm, estableciendo la
profundidad de penetración de los electrones, asegurando un tratamiento superﬁcial a la piel.
© 2014 Universidad Autónoma del Estado de México. Publicado por Masson Doyma México S.A.
Todos los derechos reservados.
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Introduction
Cutaneous T-cell lymphoma represents a complex array of
disorders with different clinical courses and therapeutic
considerations. Mycosis fungoides which affects the skin in
ﬂat patches, thin plaques, or tumors is the most common
form of cutaneous T- cell lymphoma1; consequently, more
is understood about its diagnosis, treatment and prognosis.
The chronicity of the disease results in many patients being
treat with multiple therapies in their lifetime, including
skin directed therapies, such as ultraviolet light, topical and
radiation. Total skin electron beam therapy (TSEBT) involves
treating the entire skin surface using electron beams. The
low -- energy electrons generated by a linear accelerator
penetrate only the skin, sparing deeper tissues and organs,
ensuring a safe treatment. It has complete response rate of
80--97%. It can be employed as initial therapy in the presence
of thick lesions for presenting greater therapeutic effect
than topical chemotherapy and phototherapy.
For this technique, large electron ﬁelds are required.
The objective of this project is to determine the dosimetric
parameters, include them in the planning system in order to
develop a treatment protocol for mycosis fungoides.
Materials and methods
Reviewing the literature there are different methods of
obtaining the very large ﬁelds needed for electron beam
irradiation of the total skin. Several recommendations are
made regarding the types of dosimetric measurements that
should be performed prior to initiating such irradiation
procedures. One widely used technique for TSEBT, which
involves six dual ﬁelds, known at the Stanford protocol.
According to the IAEA TRS 398 Calibration Protocol2, a
ELEKTA SYNERGY Linear accelerator was calibrated, at a
Zref=1.40 cm and a SSD of 100 cm with a 40×40 cm2 ﬁeld size
using a plane-parallel ionisation chamber and electrometer
(Scanditronix Wellhofer model PPC05 FOCUS), and a water
phantom. A 6 MeV energy was used at a high dose rate of
one Monitor Unit (MU) equivalent to 10 cGy.
Radiocromic ﬁlm (RCF) develops itself when exposed to
ionizing radiation due to the polymerization process that
takes place on its surface. It is made from polydiacetylene
and it is basically composed by hydrogen, carbon, nitrogen,
oxygen, lithium, chlorine and sodium. Its effective atomic
number is very similar to the one of water. Radiation causes
an increase in the number of polymers formed, which causes
a ﬁlm’s optical density to increase. It has many advantages
therefore it is used widely for medical purposes, includ-
ing its high spatial resolution, two dimensional dosimetry,
minimal thickness and permanent registry. The RCF opacity
can be quantiﬁed by a light transmission factor and its mea-
sure is the optical density (OD). This characteristic can be
measured by a spectrophotometer or a ﬂatbed scanner. It is
deﬁned by the equation:
OD = −log10(T) = −log10
(
I0
I
)
(1)
Where, I0 is the intensity of light incident on a ﬁlm, I is
the intensity transmitted through the ﬁlm irradiated.
Radiochromic ﬁlm handling and processing
The commercial Gafchromic EBT2 RCF (measuring
20.3×25.4 cm2) was handled according to the manu-
facturer and the AAPM Task Group 55 recommendations3.
It was cut down to segments measuring each 3×3 cm2 with
a 48 hours interval between slicing and the ﬁrst irradiation
in order to avoid any disturbance of its components due
to mechanical damage caused by the guillotine. Another
48 hours period was considered after irradiation to scan ﬁlm
segments to allow the polymerization process to ﬁnish. The
ﬁlm was protected from further irradiation or light exposure
and stored under controlled humidity and temperature
conditions.
An EPSON EXPRESSION 10000 XL scanners with EPSON
SCAN software were used to digitalize the ﬁlm before and
after irradiation. In order to reach stable temperature con-
ditions, the scanner was turned on one hour before use and
during scanning each piece was laid at the center of the
scanner to avoid uneven lighting. The ﬁlm edges were cov-
ered with a black bind to avoid modiﬁcations due to light
dispersion.
The ﬁlm orientation was identiﬁed by a mark in the right
upper corner during the entire process. Each piece endured
four scans to reduce scanner or operator interference and
a mean was calculated between the four images obtained.
RGB format (red, green and blue) was used for digitalization
with 75 points per inch spatial resolution (dpi) and 48 bits
of color depth (16 bits per channel). Images were saved in
Tagged Image File Format (TIFF) and processed with ImageJ
software. Information from the red channel was extracted
of the RCF, where the active components express their max-
imum response.
We determined the regions of interest (ROI) with the
ImageJ software. The size of a ROI was determined by the
conversion 1 pixel =0.08455mm due to image resolution
(Fig. 1).
Analyzing the information from the irradiated and non-
irradiated ﬁlms using the histogram function of the program,
we obtained the intensity (I) and the standard deviation
(SD). It is recommended the SD did not surpass 3% intensity
(Fig. 2)3. Finally, RCF response is obtained using equation 1.
Orientation
mark
X
Y
Figure 1 Sample of radiochromic ﬁlm.
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Figure 2 Regions of interest (ROI) and histogram.
Radiocromic ﬁlm calibration
In order to determine the absorbed dose in response to the
netOD of the RCF, obtaining the net optical density of the
following equation:
netOD = ODexp − ODunexp (2)
Where, ODexp is the optical density of the ﬁlm exposed
to radiation, ODunexp is the optical density of the ﬁlm not
exposed to radiation.
Measures were performed in a 30×30×30 cm3 solid water
phantom (SCANDITRONIX WELLHOFER model TYPE SP34).
The dose at which the ﬁlm was irradiated cover a range
of 0-5Gy each irradiation was of .5Gy. For each value of
absorbed dose considered in the calibration curve we used
four 3×3 cm2 ﬁlms in order to reduce the statistical uncer-
tainty. Each piece of ﬁlm was placed at a depth of 1.4 cm in
solid water which is regarded as the reference depth (Zref)
of 6 MeV electrons, with a SSD of 100 cm and with a ﬁeld
size of 10×10 cm2. Films were then scanned and the images
obtained were processed with the ImageJ software, using
a ROI of 1×1 cm2, obtaining the corresponding optical den-
sities and SD. We plotted the dose -- response calibration
curve, and a third-degree polynomial adjustment was made
to the calibration curve, obtaining the following equation:
Dose = 0.06596 + 8.33603(netOD) + 14.25653(netOD)2
+ 5.48214(netOD)3 (3)
Absorbed dose distribution at 500 cm
According to the AAPM Task Group 55 recommendations RCF
of 3×3 cm2 were obtained and were adhered to the acrylic
screen in such a manner that they would cover a human body
surface (screen acrylic dimensions 200×100 cm2). The RCF
adhered to the screen acrylic were irradiated at a SSD of
500 cm to a 1,000 MU with a 40×40 cm2 SAD ﬁeld, with a
gantry angle of 90◦ and a collimator angle of 270◦.
Percentage depth dose
The graphic of Percentage Depth Dose was obtained by
placing a solid water phantom of 30 cm3 to SAD and SSD
of 500 cm, setting speciﬁc distances at which the RCF of
3×3 cm2 were placed (0, 1, 1.2, 1.4, 1.5, 2, 3, 4, 5, 6, 7,
8, 9) this was performed under 2 forms; with acrylic screen
and acrylic screen without.
Beam energy
The beam incident on the output window of Linac can be
characterized by a distribution of maximum energy called
linac’s energy. The distribution of beam energy in the sur-
face treatment (phantom surface) is characterized by its
maximun or most probable energy Ep,o. The following rela-
tionship is used for obtain the most probable energy in the
phantom surface Ep,o, in MeV, the range practical, Rp in cen-
timeters of water, it is deﬁned like the depth of the point
where the to the descending linear portion of the curve (at
the point of inﬂection) intersects the extrapolated back-
ground (bremsstrahlung).
EP,O = C1 + C2RP + C3RP2[MeV] (2)
For water, C1=0.22 MeV, C2=1.98 MeV cm−1, and
C3=0.0025 MeV cm−2
Results and discussion
Radiocromic ﬁlm calibration to electrons
Calibration curve of radiochromic ﬁlm to electrons is in
Figure 3 which shows the behavior of electrons in their
relationship dose-netOD and the equation obtained (3). The
dose obtained to 500 cm SAD with the RCF is veriﬁed with
ionization chamber plane-parallel resulting in a percentage
difference of ± 2% for this reason the RCF can be considered
as an optimum dosimeter for electrons.
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Figure 3 Electron radiochromic ﬁlm calibration curve.
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Figure 4 Isodose distribution.
Absorbed dose distribution and percentage depth
dose at 500 cm
the absorbed dose distribution at SSD 500 cm in an area
such as to cover a robust body 200×100 cm2 is presented
in Figure 4 which shows some heterogeneity in the distribu-
tion of absorbed dose at the surface of the acrylic screen
according to the symmetry and ﬂatness beam, which will be
used like good distribution for TSEBT according to the results
of symmetry and ﬂatness of other authors.(Fig. 5)
The percentage depth dose is presented in Figure 6 which
compares the PDD with and without acrylic screen, obtained
beam’s central axis until a depth of 9 cm, in this compari-
son it can assess that acrylic screen is useful to obtain the
maximum dose of electrons at 0.4 cm depth.
Symmetry and ﬂatness
The symmetry and ﬂatness of large ﬁeld at 500 cm was calcu-
lated following the AAPM recommendations4 (Figs. 7 and 8).
The symmetry and ﬂatness horizontal and vertical of
electron large ﬁeld was calculated from the dose distribu-
tion data. The symmetry of 40×40 cm2 ﬁeld at 500 cm was:
horizontal ±0.35% and vertical ±2.1%, the ﬂatness obtained
was: horizontal ±3.62% and vertical ±14.2%. Taking into
account the experience of other groups which have reported
that at 500 cm a vertical uniformity ±8% and horizontal is
an achievable purpose to a electrons large ﬁeld in TSEBT5,6.
However, in order to achieve good beam uniformity in the
treatment plane (0.4 cm depth), the dose uniformity on the
patient’s surface cannot be better than ±15%, due to the
variable SSD, self-shielding and differences in curvatures5,6.
Beam energy
The most probable energy in the phantom surface Epo
obtained was 4.4 MeV according to the Rp of 2.1 cm such that
the acrylic screen working to degrade the energy of 6 MeV to
4.4 MeV while the x-ray contamination by bremmstrahlung
interactions was approximately of 5% to 7%.
Treatment protocol
Selection of patients
- Clinical stage: I, II, ECOG: 0-1, KPS>70 7,8.
- Hematological proﬁle and blood chemistry within normal
parameters.
- Pre-treatment with low doses of steroids (prednisone,
25mg daily), antiemetic.
Treatment technique
- Total body irradiation at 6 positions.
- 1 cm scattering screen.
- 6 MeV e-.
- 1Gy/fraction, 4 fractions/week resting Wednesday, Sat-
urday and Sunday to avoid acute skin toxicity (temporary
nail loss, anidrosis, epistaxis and parotitis).
- Duration of treatment: 9 weeks.
- Total absorbed dose: 36Gy.
Patient positioning
- Place shielding eyes, nails and genitals.
- The shield is fabricated from 1.5mm lead is being per-
sonalized for each patient by the different anatomical
dimensions, is adhered by means of transport (adhesive
plaster for clinical use).
- Place the PRC in the patient’s anatomy (vertex, face,
neck, chest, abdomen, back, arms, buttocks, groin, legs,
warm, feet, soles) between 2 and 3 RCF 2×2 cm2 by
anatomical thus making an in vivo dosimetry and perform
quality control of the absorbed dose and the dose found
in anatomical areas with greater curvature.
- Move the patient in a wheelchair to the acrylic screen to
prevent any loss of shielding or dosimetry material.
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Figure 5 Spatial dose distribution map.
- Place the patient as close (stuck) in the acrylic screen
anterior which would be the ﬁrst of the 6 positions accord-
ing to the Stanford technique.
- Throughout the placement time to explain to patients the
duration of treatment per day, and how complicated it
because of the anatomical positions which will be in the
treatment room.
Post-irradiation procedure
- Collect and store the radiochromic ﬁlms.
- The next day, reading radiochromic ﬁlms, to conﬁrm the
absorbed dose delivered so we can proceed with correc-
tions or boost dose when the patient arrives for their next
session.
Special considerations
- The depth at which 80% of the administered dose is
absorbed should not be less than 4mm, to ensure that the
epidermis and dermis are within the region of high dose.
- At a depth of 20mm the absorbed dose should not exceed
20%, to minimize damage to organs at risk.
- Boost irradiation on soles and top of the head (27Gy, 15
fractions of 1.8Gy each).
- Other body regions receiving D<80% of the prescribed dose
should receive adjuvant treatment, in this case, the tech-
nique for each ﬁeld can vary according to the depth of skin
inﬁltration of the disease. For example, if it is desired to
irradiate only the skin surface, complementary ﬁelds with
lower e- energies of 3-6 MeV can be used.
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Figure 8 Vertical symmetry and ﬂatness.
- The total absorbed dose of bremsstrahlung X-ray contami-
nation should not be greater than 0.7Gy.
- When there is lymph node involvement, higher electron
energies (6-12 MeV) are required.
For patients with advanced stage disease (IVA, IVB), with
visceral involvement, total body irradiation with photons
should be considered.
- For quality control and veriﬁcation of the treatment dose
for body regions receiving less than 80% of the prescribed
dose, RCF should be used.
Conclusions
Dosimetry of a large electron ﬁeld discloses the information
necessary to treat the whole body of a patient such as the
dose distribution to well know the absorbed dose at the sur-
face of the patient’s body, the percentage depth dose to
know the depth at which the electrons delivered their max-
imum dose (0.4 cm) and thus assuring the irradiation only
to level cutaneous. Absorbed dose distribution at 500 cm
presents symmetry and ﬂatness within limits reported by
other authors and is considered acceptable for a treatment
of Total Skin Electron Beam Therapy. The acrylic screen
with thickness of 1 cm is an effective degrader that allows
the electrons deposit their maximum dose to a 0.4 cm skin
depth. Dosimetric characterization of large ﬁeld electron
allowed to perform a treatment protocol in agreement with
the EORTC recommendations9,10.
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